FR2255076A1 - - Google Patents

Info

Publication number
FR2255076A1
FR2255076A1 FR7442541A FR7442541A FR2255076A1 FR 2255076 A1 FR2255076 A1 FR 2255076A1 FR 7442541 A FR7442541 A FR 7442541A FR 7442541 A FR7442541 A FR 7442541A FR 2255076 A1 FR2255076 A1 FR 2255076A1
Authority
FR
France
Prior art keywords
compound
syn
isomer
ceph
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7442541A
Other languages
English (en)
French (fr)
Other versions
FR2255076B1 (me
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB59517/73A external-priority patent/GB1496757A/en
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2255076A1 publication Critical patent/FR2255076A1/fr
Application granted granted Critical
Publication of FR2255076B1 publication Critical patent/FR2255076B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7442541A 1973-12-21 1974-12-23 Expired FR2255076B1 (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives
GB4300574 1974-10-03

Publications (2)

Publication Number Publication Date
FR2255076A1 true FR2255076A1 (me) 1975-07-18
FR2255076B1 FR2255076B1 (me) 1978-11-10

Family

ID=26265028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7442541A Expired FR2255076B1 (me) 1973-12-21 1974-12-23

Country Status (15)

Country Link
JP (1) JPS5844675B2 (me)
AT (1) AT344888B (me)
CH (1) CH617703A5 (me)
DE (1) DE2460537C2 (me)
DK (1) DK674674A (me)
ES (2) ES433226A1 (me)
FI (1) FI65258C (me)
FR (1) FR2255076B1 (me)
HU (1) HU172234B (me)
IE (1) IE42144B1 (me)
IL (1) IL46302A (me)
LU (1) LU71550A1 (me)
NL (1) NL7416665A (me)
NO (1) NO744621L (me)
SE (1) SE7416195L (me)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315933A1 (fr) * 1975-06-19 1977-01-28 Glaxo Lab Ltd Nouvelles cephalosporines, leur preparation et leur emploi
FR2439786A1 (fr) * 1978-10-27 1980-05-23 Glaxo Group Ltd Nouvelles cephalosporines, leur procede de preparation et leurs applications therapeutiques
FR2552432A2 (fr) * 1983-09-27 1985-03-29 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4095021A (en) 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4144392A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
US4165430A (en) 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4304770A (en) 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
GB1591439A (en) 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
GB1596278A (en) 1976-11-30 1981-08-26 Glaxo Operations Ltd 7-(-oxyimino-acetamino)cephalosporin derivatives
PH17188A (en) 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315933A1 (fr) * 1975-06-19 1977-01-28 Glaxo Lab Ltd Nouvelles cephalosporines, leur preparation et leur emploi
FR2439786A1 (fr) * 1978-10-27 1980-05-23 Glaxo Group Ltd Nouvelles cephalosporines, leur procede de preparation et leurs applications therapeutiques
FR2552432A2 (fr) * 1983-09-27 1985-03-29 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-amino thiazol- 4-yl acetique, procede de preparation

Also Published As

Publication number Publication date
AT344888B (de) 1978-08-10
CH617703A5 (en) 1980-06-13
SE7416195L (sv) 1975-09-22
FI65258C (fi) 1984-04-10
IE42144L (en) 1975-06-21
DK674674A (me) 1975-09-08
IL46302A (en) 1978-09-29
NL7416665A (nl) 1975-06-24
HU172234B (hu) 1978-07-28
FI65258B (fi) 1983-12-30
LU71550A1 (me) 1976-04-13
DE2460537C2 (de) 1987-01-22
NO744621L (me) 1975-07-21
ES433226A1 (es) 1977-07-01
IL46302A0 (en) 1975-03-13
ATA1020174A (de) 1977-12-15
IE42144B1 (en) 1980-06-18
FI371374A (me) 1975-06-22
JPS50105689A (me) 1975-08-20
ES451604A1 (es) 1977-12-16
AU7673574A (en) 1976-06-24
FR2255076B1 (me) 1978-11-10
DE2460537A1 (de) 1975-07-03
JPS5844675B2 (ja) 1983-10-04

Similar Documents

Publication Publication Date Title
FR2255076A1 (me)
ES427859A1 (es) Un procedimiento para la preparacion de compuestos de cefa-losporina.
ES479168A1 (es) Un procedimiento para la preparacion de derivados de acido 7&-metoxicefalosporanico.
ES420870A1 (es) Un procedimiento para la preparacion de eteres cefalospori-nicos.
GB1511340A (en) Thiophen saccharins
ES445348A1 (es) Un procedimiento para preparar compuestos de 3-aciloximetil-cefem.
GB1496757A (en) Cephalosporin derivatives
GB1535215A (en) Kanamycin derivatives
GB1521073A (en) Cephalosporin compounds
SE7514475L (sv) Cefalosporiner
GB1423550A (en) Method for the production of cephalosporins
ES486023A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
ES431673A1 (es) Un procedimiento para la preparacion de compuestos de 7- acilamido-7-metoxi-cefalosporina.
JPS5746990A (en) Novel cephalexin derivative and its preparation
GB1470329A (en) Antibiotic derivatives of xk-62-2 and method of production thereof
ES447615A1 (es) Un procedimiento para obtener compuesto de cefalosporina.
IE39344L (en) 7ó-alkoxy cephalosporanates and corresponding¹penicillanates
ES436198A1 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina sustituidas.
GB1501476A (en) Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives and a process for the preparation thereof
SE7509139L (sv) Forfarande for framstellning av cefalosporinforeningar
GB1389195A (en) Antibiotics
GB1512957A (en) Gephalosporin antibiotics
JPS5646885A (en) Novel cephamycin ester and its preparation
ES8307819A1 (es) "un metodo de producir derivados de cefalosporina".
JPS5746967A (en) Novel mandelic 3-hydroxy-1,2-diazine-6-yl-thiol ester and its preparation

Legal Events

Date Code Title Description
ST Notification of lapse